PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares at one-month high as Omicron fears fade

Thu, 23rd Dec 2021 09:34

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* STOXX 600 gains for third straight session

* Travel stocks rise on Omicron updates

* Banks track yields higher

* Holcim gains on $1.35 bln deal
(Updates to close)

By Anisha Sircar and Shashank Nayar

Dec 23 (Reuters) - European shares hit a one-month high on
Thursday, led by gains in banking stocks as signs the impact of
the Omicron variant may be less severe than feared led to
improved risk appetite that pushed eurozone and Treasury yields
higher.

The pan-European STOXX 600 gained 1%, marking the
third straight session of gains, boosted by banks and
travel stocks, tracking a global share rally that was
also helped by robust U.S. economic data.

Two vaccine makers said their shots protected against
Omicron as UK data suggested it may cause proportionally fewer
hospital cases than the Delta coronavirus variant, though public
health experts warned the battle against COVID-19 was far from
over.

Researchers from University of Edinburgh and Imperial
College London reported evidence that the Omicron variant was
less severe than the Delta coronavirus variant.

"The Omicron wave won't derail the economic recovery that's
well underway, it might delay it, but 2022 will have an
attractive, healthy economic environment," said Philip
Petursson, chief investment strategist at IG Wealth Management.

European government bond yields rose for the
fourth consecutive session and benchmark U.S. Treasury yields
rose to two-week highs as the trickle of risk
sentiment back into the market reduced the need for safe-haven
debt, helping push bank stocks higher.

The STOXX 600 is set to gain around 21% this year, mildly
underperforming a 26% gain in the S&P 500 and is a mere 1.5%
away from its record highs.

"This year, economies reopened from 2020 lockdowns and
benefited from all the fiscal stimulus. 2022 will be the path to
normalisation of equity returns, interest rates and economic
growth," Petursson said.

AstraZeneca added to the positive sentiment after
the drugmaker said a three-dose course of its COVID-19 vaccine
was effective against the Omicron variant, citing data from an
Oxford University lab study.

Swiss building materials company Holcim gained 1.9%
after saying it would buy Malarkey Roofing Products for $1.35
billion to expand into the growing U.S. residential roofing
market.

Flutter Entertainment rose 2.1% after announcing
it would buy Italian online gaming operator Sisal for 1.62
billion pounds ($2.16 billion), as the online betting group
looks to expand its footprint in Europe.

Continental AG added 2.5% after its CEO told a
magazine that the German automotive supplier could hit the upper
end of its profit margin outlook in 2021 as vehicle production
picked up in the fourth quarter.
(Reporting by Anisha Sircar and Shashank Nayar in Bengaluru;
Editing by Shounak Dasgupta and Barbara Lewis)

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.